Brief: Atara Biotherapeutics To Reduce Workforce By 30%
12/05/2025 21:12
May 12 (Reuters) - Atara Biotherapeutics Inc ATRA.O: ATARA BIOTHERAPEUTICS INC - TO REDUCE WORKFORCE BY 30% - SEC FILING ATARA BIOTHERAPEUTICS INC - WORKFORCE REDUCTION EXPECTED TO COMPLETE BY AUGUST 2025 - SEC FILING ATARA BIOTHERAPEUTICS INC - TO INCUR $1.4 MILLION IN SEVERANCE COSTS - SEC FILING Further company coverage: ATRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing